Skip to content

Clinical Study of Emface and Emface Submentum: Innovative Solutions for Facial Rejuvenation and Double Chin Reduction

Clinical Study of Emface and Emface Submentum: Innovative Solutions for Facial Rejuvenation and Double Chin Reduction

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260219011
Enrollment
20
Registered
2026-02-19
Start date
2025-12-05
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This study aims to assess the impact of novel radiofrequency (RF) and high intensity facial electromagnetic muscle stimulation (HIFES) technology on skin quality, muscle thickness, lifting, and volume changes. Radiofrequency high intensity facial electromagnetic muscle stimulation Muscle thickness Ultrasound Skin quality Anti-aging

Interventions

EMFACE is a non-surgical, needle-free, 20-minute facial rejuvenation treatment that simultaneously uses synchronized radiofrequency (RF) and High-Intensity Facial Electrical Stimulation (HIFES) to ton
Active Comparator Device
Emface

Sponsors

Dr. Wilai Thanasarnaksorn
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. age between 30 and 75 years 2. Asian skin type (Fitzpatrick type II-IV, scored individually by three physicians) 3. willingness to comply and abstain from other facial treatments 4. understanding of the investigative nature of the treatment.

Exclusion criteria

Exclusion criteria: 1. history of facial injectables (such as neurotoxin, filler, or biostimulators) within one month of treatment initiation 2. history of energy-based devices within six months of treatment initiation 3. presence of confounding pathologies (uncontrolled systemic disease, melasma, rosacea, connective tissue disorders, or other dermatologic diseases).

Design outcomes

Primary

MeasureTime frame
Muscle thickness (frontalis, zygomaticus major, zygomaticus minor, digastric) Baseline, 1 month, 3 months, 6 months mm/ Ultrasound,Volume of midface, lower face, and submentum Baseline, 1 month, 3 months, 6 months Cubic centimeters/ 3D imaging

Secondary

MeasureTime frame
Duration of effects: change in muscle thickness and change in volume 6 months Ultrasound & 3D imaging

Countries

Thailand

Contacts

Public ContactWilai Thanasarnaksorn

Doctor Younger

dr.wilai@yahoo.com0886177768

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026